Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert

Functional outcomes and vault after five-year follow-up of -20.00 diopters myopic phakic intraocular lens implantation

Search Title by author or title

Session Details

Session Title: Presented Poster Session 14: Phakic IOLs I

Session Date/Time: Sunday 11/09/2016 | 15:00-16:30

Paper Time: 15:20

Venue: Poster Village: Pod 2

First Author: : M.Naveiras SPAIN

Co Author(s): :    L. Fernandez-Vega Cueto   B. Alfonso-Bartolozzi   R. Montes-Mico   J. Alfonso     

Abstract Details


To evaluate refractive and visual outcomes and complications associated with phakic intraocular lens (pIOL) implantation to correct high myopia.


Instituto Universitario Fernandez-Vega, Oviedo, Spain


Uncorrected (UCVA) and best-corrected distance visual acuity (BCVA), refraction, vault and adverse effects were evaluated after five years ICMV4 pIOL implantation in 61 eyes of 45 patients


Spherical equivalent (SE) dropped from -18.32±2.37 diopters (D) to -0.88±0.52D 5-years postoperative; 61% of eyes were within ±0.75D of the target. The mean Snellen decimal BCVA and UCVA were 0.73±0.23 and 0.55±0.26, respectively. Four eyes had lost 2 or 1 lines of BCVA, 10 eyes had no lost any lines from preoperatively and more than 75% of eyes had gained 1 or more lines of BCVA 5-years postoperatively. The safety index was 1.26±0.32. The efficacy index was 0.99±0.42. Five years follow-up, mean central vault was 475.28±216.38μm. 10 eyes showed peripheral contact; with a central vault between 150 and 260 μm. One eye required cataract surgery.


Predictability, safety and effective outcomes of ICMV4 pIOL of 20.00D were excellent, as well as the postoperative complications in a long-term. A central vault of 260 μm is enough to prevent the peripheral contact between pIOL and crystalline lens in high myopic eyes.

Financial Disclosure:


Back to previous